Please provide your email address to receive an email when new articles are posted on . Overall, 1,144 bleeding events occurred by the 1-year follow-up period. There were 577 ischemic stroke or ...

People with chronic kidney disease who take the blood thinner warfarin to treat a form of irregular heartbeat are at no greater risk for stroke or death than similar patients who don't take the ...

November 22, 2011 — Patients receiving long-term, steady-dose warfarin therapy who have had stable international normalized ratios (INRs) for at least 6 months can safely go 12 weeks between dose ...

Octapharma launched Balfaxar in the U.S. in early 2024 and the response from the medical community has been outstanding. Approved last year by the U.S. Food and Drug Administration, Balfaxar ® is a ...

Use of warfarin appears to not only accelerate progression of aortic stenosis (AS) and increase the likelihood of needing an aortic valve replacement (AVR), but also may raise the risk of dying in ...

Warfarin is a derivative of coumarin which interferes with the cyclic interconversion of vitamin K and its epoxide. Vitamin K is an important factor in the normal function of the coagulation system.

As part of dietary guidance, the NHS advises against consuming two specific fruit juices if taking warfarin, which should ...